Recombinant IGF-1 promoted acute resolution of hyperalgesia [31], prevented vincristine-induced neuropathy [32], and behavioral signs of PDN and reverse neuronal hyperactivity [33], and elevated nociceptive threshold and its antinociceptive effects [34]. This evidence concerns the gene IGF1 and neuropathy.